<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>197(3)</volume><submitter>Peters FS</submitter><pubmed_abstract>Cutaneous squamous cell carcinoma (cSCC) is a serious complication after organ transplantation and patients benefit from an early risk assessment. We hypothesized that functional differences in circulating T cells may represent risk factors for post-transplant cSCC development. Here, we analysed genome-wide DNA methylation of circulating T cells of kidney transplant recipients before the clinical onset of cSCC, to identify differences associated with post-transplant cSCC development. This analysis identified higher DNA methylation of SERPINB9, which is an intracellular inhibitor of granzyme B, a protein that induces apoptosis in target cells. High DNA methylation of SERPINB9 in circulating T cells was confirmed in a second patient cohort during recurrent cSCC, indicating that high SERPINB9</pubmed_abstract><journal>Clinical and experimental immunology</journal><pagination>341-351</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6693965</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer.</pubmed_title><pmcid>PMC6693965</pmcid><pubmed_authors>Peters FS</pubmed_authors><pubmed_authors>Mooyaart AL</pubmed_authors><pubmed_authors>van de Wetering J</pubmed_authors><pubmed_authors>van den Bosch TPP</pubmed_authors><pubmed_authors>Peeters AMA</pubmed_authors><pubmed_authors>Betjes MGH</pubmed_authors><pubmed_authors>Baan CC</pubmed_authors><pubmed_authors>Boer K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer.</name><description>Cutaneous squamous cell carcinoma (cSCC) is a serious complication after organ transplantation and patients benefit from an early risk assessment. We hypothesized that functional differences in circulating T cells may represent risk factors for post-transplant cSCC development. Here, we analysed genome-wide DNA methylation of circulating T cells of kidney transplant recipients before the clinical onset of cSCC, to identify differences associated with post-transplant cSCC development. This analysis identified higher DNA methylation of SERPINB9, which is an intracellular inhibitor of granzyme B, a protein that induces apoptosis in target cells. High DNA methylation of SERPINB9 in circulating T cells was confirmed in a second patient cohort during recurrent cSCC, indicating that high SERPINB9</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Sep</publication><modification>2026-05-07T18:07:48.622Z</modification><creation>2019-08-23T07:04:51Z</creation></dates><accession>S-EPMC6693965</accession><cross_references><pubmed>31059128</pubmed><doi>10.1111/cei.13309</doi></cross_references></HashMap>